Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tennenbaum Capital Partners (TCP) is a specialized investment management firm that focuses on middle-market credit and special situation opportunities, including significant investments in the healthcare and life sciences sectors. Founded in 1999 and headquartered in Santa Monica, California, the firm provides creative capital solutions such as senior secured loans, junior capital, and equity investments to support growth, acquisitions, and restructurings. In August 2018, TCP was acquired by BlackRock, where it was integrated into BlackRock’s Global Credit platform to enhance its private credit capabilities. The firm is well-regarded for its disciplined credit analysis and serves as the investment advisor to the publicly traded business development company, TCP Capital Corp. (NASDAQ: TCPC).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tannenbaum Capital Partners.